Richard Lavigne
Internal Medicine · Albany, NYNPI 1770575896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 518 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,367 and has fallen 80.3% since, to $467 in 2023. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 518 payments — averaging $14.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$764
- GSK$669
- Boehringer Ingelheim$613
- AbbVie$514
- Merck$500
- plus $3K from 34 others
What the payments were for
- Food & beverage$7,612100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 122 | $1,529 |
| AstraZeneca | 25 | $764 |
| GSK | 50 | $669 |
| Boehringer Ingelheim | 41 | $613 |
| AbbVie(2 entities) | 40 | $514 |
| Merck | 43 | $500 |
| Pfizer | 24 | $351 |
| Johnson & Johnson | 13 | $251 |
| Novartis | 16 | $214 |
| Lilly USA, LLC | 14 | $200 |
| Sanofi-aventis U.S. LLC | 15 | $193 |
| Abbott | 9 | $182 |
| E.r. Squibb & Sons, L.L.C. | 11 | $170 |
| Amgen | 10 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $147 |
| Bayer | 9 | $133 |
| Biohaven Pharmaceuticals, Inc. | 12 | $127 |
| Renalytix AI, Inc. | 4 | $99 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $93 |
| Amarin Pharma, Inc. | 6 | $92 |
| Eisai Inc. | 4 | $92 |
| Astellas Pharma US Inc | 5 | $80 |
| Sanofi Pasteur Inc. | 3 | $50 |
| Sunovion Pharmaceuticals Inc. | 3 | $46 |
| Currax Pharmaceuticals LLC | 3 | $41 |
| Mannkind Corporation | 3 | $38 |
| Kowa Pharmaceuticals America, Inc. | 3 | $36 |
| Genentech USA, Inc. | 2 | $29 |
| Esperion Therapeutics, Inc. | 2 | $27 |
| Sumitomo Pharma America, Inc. | 2 | $26 |
| Edwards Lifesciences | 1 | $18 |
| Insulet Corporation | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| Biogen | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
| Seqirus USA Inc | 1 | $13 |
| Optinose US, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$114
- BREZTRI AEROSPHERE$114
- FASENRA$114
- SYMBICORT$114
- BREZTRI$113
How this compares
$7,612 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Albany
- Scott BeegleAlbany$1.9M
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.